Delivery Order SPE2DB22D2007-SPE2DB24FJ4GJ

Award Date 7/16/24
Potential Completion Date 7/17/24
Potential Value $29K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,137.58 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,536.04 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a specialty medication. The award has an ultimate completion date of August 12, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award is a delivery order valued at $10,205.77 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, with a period of performance through March 31, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,599.72 firm fixed-price delivery order is for the provision of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,771.44 firm fixed-price delivery order is for the provision of RINVOQ ER 15 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award is a delivery order worth $47,077.25 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) and is a firm fixed-price delivery order for the supply of RINVOQ ER 30 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen Drug Corp is the prime contractor and the contract does not have a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,603.26 firm fixed-price delivery order is for the provision of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,974.14 firm fixed-price delivery order contract is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a Delivery Order (DO) valued at $29,394.88 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RINVOQ ER 30 MG TABLET, a specialty medication. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,812.25 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ4GJ
    Delivery Order

This federal contract award is a delivery order valued at $28,694.04, issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the provision of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, with a performance period through July 2024. This contract is not associated with any specific set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, covering similar medical products and prescription drugs.

Generated 5/17/25, 9:47 AM